Itb-med Llc
Clinical trials sponsored by Itb-med Llc, explained in plain language.
-
Trial tests new drug mix to protect transplanted kidneys
Disease control OngoingThis study is testing a new combination of drugs designed to prevent the body from rejecting a newly transplanted kidney. It will compare this new regimen to the current standard treatment in 76 adult patients. The main goal is to see if the new combination is safe and works as w…
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Breakthrough trial aims to free kidney patients from lifelong drugs
Disease control OngoingThis study is testing a new drug combination to see if it can safely train a kidney transplant patient's immune system to accept the donated organ without needing lifelong anti-rejection medications. It involves 18 adult patients who received a kidney from a living donor. The app…
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC